Busulfan

FDA Approved: * December 22, 2015
Pharm Company: * PHARMAFORCE
Category: Cancer

Busulfan (Myleran, GlaxoSmithKline, Busulfex IV, Otsuka America Pharmaceutical, Inc.) is a chemotherapy drug in use since 1959. It is a cell cycle non-specific alkylating antineoplastic agent, in the class of alkyl sulfonates. Its chemical designation is 1,4-butanediol dimethanesulfonate. Contents 1 History 2 Indications 3 Availability 4 Side effects 5 Dosing, administration, and pharmacokinetics 6 Drug interactions 7 Pharmacology 8 Complexation 9 References 10 External links History B... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Busulfan 6 mg/ml Intravenous Injection, Solution
NDC: 0409-1112
Labeler:
Hospira, Inc.
N/A 6 mg/ml Intravenous Injection
NDC: 0517-0920
Labeler:
American Regent, Inc.
Busulfan 60 mg/10ml Intravenous Injection
NDC: 14789-013
Labeler:
Nexus Pharmaceuticals LLC
Busulfan 6 mg/ml Intravenous Injection
NDC: 16729-351
Labeler:
Accord Healthcare, Inc
Busulfan 6 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 25021-241
Labeler:
Sagent Pharmaceuticals
Busulfan 6 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 45963-640
Labeler:
Actavis Pharma, Inc.
Busulfan 6 mg/ml Intravenous Injection
NDC: 51817-170
Labeler:
Pharmascience Inc.
Busulfan 6 mg/ml Intravenous Injection
NDC: 60505-6177
Labeler:
Apotex Corp.
Busulfan 6 mg/ml Intravenous Injection
NDC: 65219-160
Labeler:
Fresenius Kabi USA, LLC
Busulfan 6 mg/ml Intravenous Injection
NDC: 67457-893
Labeler:
Mylan Institutional LLC

Related Brands

Drugs with the same active ingredients